BRIEF-Intellipharmaceutics reports Q1 loss per share $0.09
April 15 (Reuters) - Intellipharmaceutics International Inc
* Intellipharmaceutics announces first quarter 2016 results
* Q1 loss per share $0.09
* Q1 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S
* Plan to file new drug application for rexista oxycodone xr within three months on basis that no phase iii studies required
* Progress on rexista oxycodone xr continues, nda user fee waiver request filed Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.